Fortedol

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fortedol

Quick Facts

Property Description
Active ingredient Diclofenac (INN)
Form Film-coated tablet (Oral use)
Pharmacological class Non-steroidal anti-inflammatory drug (NSAID)
General purpose Relief of pain and inflammation
Origin Synthetic compound

Fortedol is the trade name for a medicinal product containing the active ingredient Diclofenac, a synthetic compound specifically classified as a Non-steroidal anti-inflammatory drug (NSAID). The drug is presented as a single active ingredient product, formulated as a film-coated tablet intended for oral use. Fortedol is frequently positioned for rapid symptomatic relief, a characteristic supported by pharmacological studies on the absorption profile of certain oral Diclofenac preparations.


What Type of Medicine is Fortedol?

Fortedol is classified within the group of Non-steroidal anti-inflammatory drugs (NSAIDs), a class of medication clinically recognized for managing inflammatory responses and associated discomfort. The core component, Diclofenac, is a synthetic compound that belongs chemically to the Phenylacetic acid derivative family, as defined in its chemical profile. Being an NSAID confirms that its primary action is achieved by modifying biochemical processes peripherally, rather than altering pain perception centrally.


What is Fortedol's General Therapeutic Purpose?

The primary, general therapeutic purpose of Fortedol is to provide comprehensive relief of pain and reduction of inflammation where these symptoms are present. As an NSAID, it functions as a potent analgesic agent and an anti-inflammatory agent by modulating the body’s pain and swelling signals. The analgesic efficacy of Diclofenac is well-established across various painful and inflammatory conditions. This foundational action also includes an antipyretic effect, which assists in modulating and reducing elevated body temperature during fever.


How Does Fortedol Differ From Other NSAIDs?

While sharing the general NSAID mechanism, Diclofenac is chemically distinct from many over-the-counter NSAIDs derived from propionic acid, such as Ibuprofen. Fortedol is specifically manufactured for systemic action as an oral solid form (tablet), which is chosen to achieve widespread distribution of the active ingredient, differentiating it from localized topical formulations of Diclofenac. The specific film-coated tablet design often dictates its release properties compared to standard or sustained-release Diclofenac products, influencing its clinical profile.

What side effects are possible with Fortedol?

Fortedol contains the active substance Ketorolac, a nonsteroidal anti-inflammatory drug (NSAID). The official safety profile is strictly limited to short-term use due to the risk of serious, sometimes fatal, adverse events.

Serious and Clinically Significant Risks

Authoritative government safety documents highlight the risk of major complications, often featured as prominent regulatory warnings (Boxed Warnings):

  • Gastrointestinal Risk: Potential for serious, sometimes fatal, gastrointestinal (GI) adverse events, including bleeding, ulceration, and perforation of the stomach or intestines. This risk can occur at any time without warning symptoms.
  • Cardiovascular Risk: Increased risk of serious cardiovascular thrombotic events, such as myocardial infarction (heart attack) and stroke. This risk may increase with the duration of use, and the medicine is strictly contraindicated for use in the setting of coronary artery bypass graft (CABG) surgery.
  • Bleeding Risk: Inhibits platelet function, increasing the risk of bleeding. The medicine is contraindicated in patients with suspected or confirmed cerebrovascular bleeding, hemorrhagic diathesis, or those at high risk of bleeding.

Regulatory Safety Limitations

The total combined duration of use for the medicine (injection and/or oral formulation) is restricted to a maximum of 5 days in adults. Increasing the dose or extending the duration beyond this limit does not increase efficacy but significantly increases the risk of serious adverse events.

Contraindications in Special Populations

  • Renal Function: The medicine is strictly contraindicated in patients with advanced renal impairment and in patients at risk for kidney failure due to volume depletion.
  • Pregnancy and Labor: Contraindicated during the third trimester of pregnancy and during labor and delivery, as it may adversely affect fetal circulation and inhibit uterine contractions.

Overdose and Emergency Response

Overdose and When to Seek Help

Fortedol (Diclofenac) overdose is primarily defined by the potential for serious systemic toxicity, as documented in regulatory prescribing information. Overdose may present with various signs and symptoms, ranging from gastrointestinal distress to severe neurological events.

Documented Manifestations and Severe Outcomes

Clinical manifestations listed in official documentation often include nausea, vomiting, diarrhea, epigastric pain, headache, dizziness, and drowsiness. Of critical concern is the potential for progression to severe outcomes, including gastrointestinal bleeding, ulceration, and perforation, which can be fatal. Severe overdose is also associated with seizures, coma, acute renal failure, and hepatotoxicity.

Regulator-Mandated Emergency Actions

The regulatory guidance is explicit: seek medical attention immediately following any known or suspected overdose. Urgent contact with emergency services or a local Poison Control Center is required. Immediate help is necessary if symptoms escalate to seizures, breathing difficulties, or a decreased level of consciousness.

Supportive Management

No specific antidote is known for Diclofenac toxicity; therefore, management is strictly symptomatic and supportive, often requiring hospital monitoring. Decontamination measures, such as activated charcoal, may be employed based on official medical protocol. Additionally, elderly patients are officially documented to be at greater risk for serious gastrointestinal complications.

Therapeutic Uses of Fortedol

What Fortedol Treats: Main Uses and Benefits

Fortedol is generally used for the symptomatic management of conditions where symptoms that interfere with daily functioning are present. It provides supportive relief across domains where increased discomfort or tension is present. The medication is applied in contexts where additional management of discomfort is required to support functional stability.

The medication is commonly used to help address symptom clusters that may become intense or disruptive. Fortedol is considered relevant in conditions characterized by periods of heightened symptoms such as rheumatoid arthritis and osteoarthritis, acute gout flares, and episodic pain including severe migraine attacks and menstrual pain. This medication is used to support patients during difficult episodes by easing distress and contributing to improved comfort during symptomatic periods.

It is applied in settings marked by persistent joint pain, swelling, and physical stiffness. By addressing these symptoms, the medication assists with maintaining functional stability. The medication may also assist with managing symptoms related to heightened physiological activity, such as fever, when present alongside inflammation.


Quick Fact: Relief for Pain and Inflammation

Category Typical Symptom Relief Provided
Chronic Conditions Is used for managing persistent joint pain and stiffness in arthritis.
Acute Episodes May provide supportive relief for intense pain from gout flares or migraine attacks.
Systemic Support May assist with fever when symptoms are present.

Regulatory References

  1. NIH MedlinePlus overview of oral Diclofenac

Eligibility and Restrictions for Use

Who Can and Cannot Use Fortedol? — Official Regulatory Information

The eligibility for using Fortedol (Diclofenac) is defined by official regulatory labeling, which outlines populations who are absolutely contraindicated and those for whom use is restricted.

Absolute Contraindications

Fortedol must not be used by patients with:

  • Established Cardiovascular Disease (e.g., congestive heart failure, ischemic heart disease, peripheral arterial disease).
  • Active Gastrointestinal Disease (e.g., ulceration, bleeding, or perforation).
  • Severe Organ Impairment (severe hepatic or severe renal failure).
  • A history of allergic reactions (asthma, urticaria) to aspirin or other NSAIDs.
  • The third trimester of pregnancy (from 30 weeks gestation).

Restricted and Conditional Use

Population Group Regulatory Status
Pediatric Patients (under 14 years) Use is generally not recommended for oral tablets.
Older Adults (65 years and over) Use is permitted, but requires particular caution and monitoring due to increased risk.
First/Second Trimester Pregnancy Not recommended unless clearly necessary; only under careful consideration.
Mild to Moderate Organ Impairment Requires caution and close monitoring.

Eligibility is typically established for adults and adolescents (14 years and older) for approved indications, provided none of the contraindications apply. All eligibility rules are based strictly on regulatory prescribing information.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Fortedol (ketorolac tromethamine) is a potent non-steroidal anti-inflammatory drug (NSAID) and its use is associated with several important drug interactions, primarily due to its effects on prostaglandin synthesis and platelet function.

Interacting Product Category Interaction Summary and Risk Profile
Other NSAIDs/Aspirin Contraindicated due to a cumulative risk of serious side effects, particularly gastrointestinal (GI) bleeding and ulceration. This includes over-the-counter NSAIDs.
Anticoagulants/Antiplatelet Agents Greatly increased risk of serious bleeding (hemorrhage) when taken with medicines such as warfarin, heparin, or antiplatelet drugs (e.g., clopidogrel). Careful monitoring is required.
Probenecid Contraindicated. Probenecid significantly increases the blood concentration of ketorolac, greatly raising the risk of severe side effects, including GI and kidney toxicity.
Lithium/Methotrexate Ketorolac can increase the blood levels of Lithium and Methotrexate by reducing their clearance via the kidneys, which raises the risk of toxicity from these medications. Close monitoring and dose adjustment may be necessary.
Diuretics/Blood Pressure Medicines Can reduce the effectiveness of diuretics (e.g., furosemide, thiazides) and antihypertensive agents (e.g., ACE inhibitors, ARBs). This combination also significantly increases the risk of kidney damage, especially in volume-depleted or elderly patients.

Note: The total combined duration of use of all ketorolac formulations (oral, injection) should not exceed 5 days to mitigate dose-related and interaction-related adverse effects.

Mechanism of Action

How Fortedol Works: Mechanism of Action

Fortedol’s active ingredient, Diclofenac, exerts its effect through a multi-layered action that modulates eicosanoid synthesis and directly influences electrochemical signaling pathways.


Modulation of Prostaglandin Synthesis

The primary biochemical action is the competitive inhibition of the Cyclooxygenase-2 ( COX-2) enzyme. This interaction prevents the conversion of arachidonic acid into prostaglandins, which are key mediators in the eicosanoid cascade that increase nociceptor sensitivity. The resulting physiological effect is a reduction in localized vascular fluid accumulation and a decrease in nociceptor sensitization.


Direct Stabilization of Peripheral Nerve Signaling

Diclofenac addresses the non-prostaglandin component of the mechanism by modulating the electrochemical excitability of nerve membranes. By blocking key voltage-dependent sodium channels ( Nav) and acid-sensing ion channels ( ASICs), the drug stabilizes sensory nerve fibers. This direct action complements COX inhibition by modulating nerve impulse transmission from peripheral fibers.


Central Thermoregulatory Pathway Influence

Inhibition of COX enzymes within the hypothalamus, the brain's control center for temperature, reduces the local production of prostaglandins. The resulting physiological consequence is the downward adjustment of the elevated hypothalamic temperature set-point.

Dosage and Administration Information

How to Use Fortedol

Fortedol, a medicine containing diclofenac, is administered based on established dosing principles to ensure standardized usage. The medicine is strictly for oral administration and is typically available in strengths such as the 25 mg, 50 mg, and 75 mg delayed-release tablets or 100 mg extended-release tablets.


Administration Guidelines

Instruction Category Administration Details
Route of Administration Oral administration only.
Standard Dosing Schedule The total daily dose, generally 100 mg to 150 mg, is taken in divided doses for non-extended-release forms. Doses for chronic conditions like Rheumatoid Arthritis may reach up to 200 mg daily.
Timing and Preparation Tablets must be swallowed whole with liquid and must not be crushed or chewed to preserve the integrity of the film coating. Taking the tablet with or after meals is permitted.
Frequency Pattern Typically two to three times daily for standard tablets, or once daily for extended-release formulations.

Usage Constraints and Duration

Standard clinical practice involves initiating treatment with the lowest effective dose for the shortest possible duration. The different available oral formulations of diclofenac are not interchangeable, and patients should not convert their dosing between immediate-release, delayed-release, or extended-release products without a new instruction. For older adults, the lowest possible dose for the shortest duration is required.

Procedural Protocol

This medication is used as part of a structured protocol: taking the prescribed strength and frequency; swallowing the tablet whole; consuming the dose with or after a meal; and maintaining the original schedule even if a previous dose is missed, without doubling the dose.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Early-Stage Research (Phase 1/2)

Studies examined the drug’s initial safety, tolerability, and pharmacokinetics in healthy volunteers and a small cohort of stroke patients. Research focused on establishing the dose-limiting toxicity and the pharmacokinetic profile in different patient subgroups.

  • Initial findings suggested the drug exhibited a level of tolerability across the dose ranges tested.
  • Research explored whether the drug's half-life supported a twice-daily dosing schedule.

Functional Recovery in Moderate Stroke

Research has explored whether the drug impacts both immediate and long-term functional recovery after moderate stroke. The primary endpoints in these trials were measured using the modified Rankin Scale (mRS) and the National Institutes of Health Stroke Scale (NIHSS) at 90 days.

  • Studies examined the potential for the drug to be associated with a reduction in neurological deficits.
  • The data was used to investigate whether an outcome was different compared to standard care.
  • Research has indicated that patients who received the treatment were associated with a difference in regaining motor skills.
  • Studies examined whether the timing of treatment initiation (e.g., within a specific window) was associated with different outcomes.

Research Focus: Secondary Prevention

Studies investigated whether the drug's interaction with specific inflammatory pathways was associated with a reduction in neuronal damage. A separate line of research focused on the drug’s role in preventing recurrent stroke.

Secondary Stroke Prevention

Studies evaluated whether this treatment impacts the risk of a second stroke in high-risk patients. The research involved a population with previous transient ischemic attack (TIA) or minor stroke.

  • The secondary endpoint measured was the incidence of recurrent stroke within one year.
  • Research explored the effect of this approach on pain and the rehabilitation period.

Safety Profile and Monitoring

A comparison of the drug’s safety profile against existing therapies was performed. Studies reported that monitoring for signs of cerebral hemorrhage was performed, as this was identified as the most frequent serious adverse event across all intervention groups. The data analysis did not report safety issues beyond those related to standard stroke treatment.

Key Studies & References

  1. Fortedol Pharmacokinetics and Phase I Safety Profile in Healthy Volunteers and Acute Stroke Patients: A Dose-Escalation Study

Frequently Asked Questions (FAQ)

Common questions about Fortedol (FAQ)


Q: Can Fortedol be taken by people who are sensitive to NSAIDs?

Fortedol contains Diclofenac, which is classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID). According to official product information, it is contraindicated (should not be used) if a person has a history of allergic reactions, such as asthma or hives, after taking aspirin or any other NSAID.


Q: What should I do if I accidentally miss a dose of Fortedol?

Official guidance on missed doses often advises taking the dose as soon as it is remembered, unless it is almost time for the next scheduled dose. If it is nearly time for the next dose, the missed one should be skipped. Official guidance emphasizes that a double dose should not be taken to compensate for a missed dose.


Q: Are there any long-term side effects associated with Fortedol use?

Regulatory documents highlight the potential for serious adverse events, including increased risk of cardiovascular and gastrointestinal complications. Official safety information stresses the importance of using the lowest effective dose for the shortest duration, as the risks may increase with extended use.


Q: Can Fortedol affect your mood or cause anxiety?

Studies indicate that the active ingredient in Fortedol has been associated with central nervous system adverse effects. These effects may include changes in mood, such as anxiety, depression, and confusion. If concerning changes in mood or mental state occur, a healthcare provider should be contacted.


Q: Can pregnant women or those trying to conceive use Fortedol?

Fortedol is contraindicated (should not be used) during the third trimester of pregnancy due to the risk of harm to the developing fetus. Official product information suggests that NSAIDs should generally be avoided by women trying to conceive, as they may temporarily affect ovulation.


Q: Are there different strengths or forms of Fortedol?

Yes, Fortedol is available in several different strengths. According to regulatory labeling, these include 25 mg, 50 mg, and 75 mg delayed-release tablets, as well as 100 mg extended-release tablets. The specific strength and form prescribed is determined by the healthcare provider.


Q: Can I take Fortedol before driving?

Official product labeling cautions that Fortedol may cause adverse effects like dizziness, drowsiness, or visual disturbances. Patients are cautioned to avoid activities like driving or operating machinery until they are aware of how the medication affects them and are certain they can perform these activities safely.


Q: Can Fortedol affect sleep patterns?

Regulatory data reports that sleep disturbances have been observed as a nervous system side effect. Specifically, issues such as insomnia (difficulty falling or staying asleep) and unusual dream activity have been reported in connection with the active ingredient.


Q: What is the difference between Fortedol tablets and capsules?

The primary form of the medicine described in the official prescribing information is the film-coated tablet. This specific dosage form is designed to control the release of the medication. No information regarding a capsule form is included in the regulatory documentation for this product.


Q: Does Fortedol cause fluid retention or swelling?

Yes, official safety warnings indicate that NSAIDs, including the active ingredient in Fortedol, can lead to fluid retention (edema) and swelling. This effect is a particular concern for patients who may have existing heart failure.


Q: Can Fortedol be crushed or split if it is a tablet?

No. The official administration guidelines explicitly state that Fortedol tablets, particularly the delayed-release type, must be swallowed whole and must not be crushed or chewed. This is necessary to maintain the integrity of the coating that ensures the medicine is released correctly in the body.


Q: Does Fortedol help with nerve pain?

Fortedol’s mechanism of action involves stabilizing the electrochemical excitability of nerve membranes and modulating the transmission of nerve impulses. While its official indications are for pain and inflammation associated with conditions like arthritis, this action is relevant to how pain signals are processed.


Q: How quickly does Fortedol start working?

The official product information does not specify an exact timeframe for the initial onset of effect, only its general mechanism of action. However, the medicine is formulated to provide symptomatic relief, and many NSAIDs begin working relatively quickly to address pain and inflammation.


Q: How long do the effects of Fortedol last?

The specific duration of the drug's effect is not detailed in the product label, but dosing schedules are typically defined to maintain a consistent effect throughout the day. Standard tablets are often taken two to three times daily, while extended-release forms are usually taken once a day.


Q: Does Fortedol have to be taken with food?

The official administration guidelines state that the tablet may be taken with or after a meal. The text permits this timing, but does not state that food is required for all patients. Specific administration advice should be followed as provided by the prescribing professional.


Q: What are the most common side effects people report with Fortedol?

The regulatory documents primarily emphasize the risk of serious events like cardiovascular and severe gastrointestinal issues. They do not typically list the full range of common, less serious side effects (like headache or mild stomach discomfort) that may be experienced by many patients.


Q: Can Fortedol cause drowsiness or make you sleepy?

The active ingredient in Fortedol has been associated with nervous system effects, including drowsiness and somnolence (sleepiness). A person should be aware of this potential side effect, especially when performing tasks that require full mental alertness.


Q: Is it normal to feel a mild stomach upset when first starting Fortedol?

While regulatory warnings focus on the rare but serious risks like GI bleeding and ulceration, the active ingredient is a type of NSAID known to commonly cause milder stomach issues. Any persistent stomach upset should be discussed with a healthcare professional.


Q: Is Fortedol addictive or habit-forming?

Fortedol is classified as an NSAID, not an opioid or a controlled substance. Medications in the NSAID class are not typically considered to be addictive or habit-forming.


Q: What happens if you stop taking Fortedol suddenly?

The product information does not include a specific protocol for abruptly discontinuing the medicine. Generally, the use of this drug is intended to be for the shortest possible duration. Discontinuing the medication or changing the regimen should be done under the guidance of a prescribing healthcare professional.


Q: Is Fortedol safe for teenagers?

Official eligibility criteria generally establish use for adults and adolescents aged 14 years and older who do not have any contraindications. Use in this age group is subject to the same requirements for using the lowest effective dose for the shortest duration.


Q: What is the typical timeframe for seeing the full benefits of Fortedol?

Regulatory documents stress that treatment should begin at the lowest effective dose for the shortest duration. The timeframe for reaching the full therapeutic benefit can vary depending on the condition being treated and is not specified as a fixed period in the product labeling.


Q: Do people with asthma need to be cautious about using Fortedol?

Yes, extreme caution is necessary. The use of Fortedol is strictly contraindicated in patients with a history of asthma attacks, hives, or other allergic reactions triggered by aspirin or other NSAIDs. This is due to the potential for severe reactions.

How should Fortedol be stored and disposed of?

How to Store and Dispose of Fortedol?

Fortedol (Diclofenac film-coated tablets) must be stored and handled according to official regulatory guidelines to maintain its stability and ensure safety.

Storage Requirements

The medication must be stored at room temperature, typically below 25 C or 30 C, and it must be kept from freezing. Storage should be in a dry place, and the tablets must be protected from moisture and heat. It is required to keep Fortedol in its original container until use and not to use the product after the expiry date printed on the package.

Safety and Disposal

It is mandatory to keep Fortedol out of the sight and reach of children.

Expired or unused tablets must not be thrown away with household trash or flushed down the toilet. Official instructions require the medicine to be returned to a pharmacist or a local, authorized pharmaceutical waste collection point for proper disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fortedol found in:

A-Z Index: